Almogim 2025: Earnings Improved, But the Capital Markets Still Fund the Pace

Getting To Know The Company

Almogim no longer looks like a small residential developer with a handful of isolated projects. By 2025 it had become a broader platform, with 1,105 units under construction, 1,640 units in planning and land reserves, and another 4,641 urban-renewal units where the required majority has already been secured. That is what is working now: scale expanded, revenue rose to ILS 422.2 million, and net profit recovered to ILS 33.8 million after a very weak 2024.

But a superficial read misses the core issue. Almogim is not short of projects right now. It is short of frictionless capital. Most of its assets sit inside construction inventory, buyer receivables, and investments in project companies, while cash and cash equivalents stayed at only about ILS 29 million. This is why 2026 does not read like a clean harvest year. It reads like a funded proof phase: the company has to show that a much larger project base can translate into equity release, collections, and cash that actually reaches the listed-company layer.

The second common mistake is to focus only on net profit. Part of the 2025 improvement came from sources that sit above, or ahead of, cash available to common shareholders: fair-value recognition in urban-renewal partnerships, profit from equity-accounted investees, and sales supported by financing incentives that have become a core commercial tool. That does not mean the improvement is fake. It does mean the gap between value created and value accessible to shareholders is still material.

The market layer says something similar. Market cap stands at about ILS 478 million versus equity of ILS 379 million, but trading liquidity is very weak, with the latest daily equity turnover below ILS 10,000. Short sellers are barely involved, with short float of about 0.13% and SIR of 1.27 days. In other words, the debate here is not a technical short story. It is a capital-conversion story.

The right way to read the company therefore starts with a simple distinction: the project engine is working, but the active bottleneck is capital. Any discussion of urban renewal, land reserves, growth, or value has to pass first through a narrower question: can current execution projects release equity fast enough to fund the next growth layer without turning every operational win into another financing round.

Events And Triggers

Funding And Capital

The first trigger: Almogim built a wider capital base in 2025, but it also showed that it still needs one. In January 2025 it raised about ILS 59.2 million gross in a public equity offering. In October 2025 it added a private placement to Migdal for ILS 50 million gross. In February 2025 it issued bond series XII for about ILS 237 million net, and in January 2026 it expanded that same series by another ILS 59.1 million of proceeds. This is positive because it shows access to capital markets during a difficult period for the sector. It is also a yellow flag, because a company that repeatedly needs public markets to maintain growth pace has not yet reached self-funding mode.

The second trigger: The draft trust-deed filings for a possible bond series XIII, published in March 2026, are not completed financing and should not be treated as if the issuance already happened. But their existence still matters. They show that the public debt market remains part of Almogim's operating model.

The third trigger: The dividend approved in March 2026 was only ILS 5 million, even though management had initially intended to recommend ILS 10 million. The stated reason was caution in light of market conditions and uncertainty. That is a sensible capital-allocation choice, but it is also a clear signal that management itself is not reading 2026 as a year of surplus cash.

Projects, Permits And Partners

The fourth trigger: Almogim expanded its asset base aggressively in 2025. It acquired the Amishav project in Petah Tikva, won East Park in Yavne, acquired the Chatzavim project in Rishon LeZion, increased its stake in South Approaches Haifa, and won a Be'er Yaakov land tender in December 2025 with land cost of about ILS 56.1 million plus development spending of about ILS 17.8 million. This is exactly why the balance sheet expanded so quickly.

The fifth trigger: Several post-balance-sheet developments make the story easier to read positively. In stage C of the Shamayim VeAretz project in Rehovot, a full building permit was received for a 96-unit tower, meaning the project now has permit coverage for all 311 units. That materially improves execution visibility for one of the company's key projects. In addition, a land-financing agreement was signed in March 2026 for Be'er Yaakov at ILS 58.3 million, plus a separate VAT facility, which reduces the immediate equity burden on that new project.

The sixth trigger: In East Park Yavne, the company signed a term sheet in January 2026 with a financial investor that would fund 75% of the land-stage equity and 75% of future equity in the project, up to roughly ILS 27 million. On the surface this looks ideal. But this type of solution has a clear price: the investor receives 40% of the rights, and that can rise to 45% if profitability disappoints or delays occur. Almogim is solving part of the capital burden by sharing upside.

The seventh trigger: Neve Tzedek delivered one of the cleaner commercial proof points after year-end. By the end of 2025, 9 of 18 apartments had been sold for total consideration of about ILS 313 million including VAT. The company estimated that the agreements signed in the fourth quarter alone should generate project-level gross profit of ILS 25 million to ILS 30 million, while Almogim's share in the project is 40%. If deliveries and collections follow through, this can turn from theoretical upside into hard evidence.

The eighth trigger: The possible purchase-tax refund in subsidized-housing projects is a potential bonus, not the core thesis. Based on the February 2026 update, the company estimates total effect of roughly ILS 20 million before tax, including linkage and interest and net of expenses, if the process is completed in its favor. The market may focus on it in the near term, but for now it remains conditional value rather than locked-in cash.

Efficiency, Profitability And Competition

What Actually Drove 2025

Earnings came back, but not only from execution. Revenue rose 41.6% to ILS 422.2 million and gross profit rose 41.1% to ILS 81.4 million. That is real improvement, driven mainly by wider execution and sales activity. The problem is that the jump in pre-tax profit to ILS 43.5 million did not come only from that core layer. Net finance expense increased to ILS 37.2 million, so the bridge was closed mainly by ILS 26.1 million of other income and ILS 3.8 million of profit from associates.

That other income is tied mainly to fair-value recognition in the Amishav and Bialik urban-renewal partnerships, which makes the analytical point important: Almogim began pulling future project value into the income statement before that value had fully turned into shareholder-accessible cash. At the same time, profit from associates improved mainly because of Neve Tzedek. Put simply, 2025 was the year accounting started to recognize part of the future value before the listed-company cash line fully felt it.

This was even more obvious in the fourth quarter. Revenue rose to ILS 155.7 million and net profit jumped to ILS 28.8 million, but again this did not look like a quarter driven only by plain-vanilla deliveries. Other income contributed ILS 23.2 million and associates contributed ILS 7.7 million. That does not make the quarter weak. It does mean the market should ask how much of this earnings level can repeat without another round of fair-value recognition.

Sales Quality: Growth Was Also Helped By Customer Financing

The most sensitive issue in the report is sales quality. Almogim describes contractor loans as a core commercial model in projects with more than a year left to completion, and it explains why: the tool helps raise sales, improves customer quality through bank underwriting, and channels proceeds into project-lending accounts earlier. From a developer's perspective, that argument makes sense.

But there is also a yellow flag. In one part of the annual package the company says contractor-loan deals represented 39% of 2025 transactions, while in another part it refers to a lower level of 26%. The revenue impact of these incentives also appears in two close but different versions, about ILS 4.9 million and about ILS 5.3 million. The numerical gap itself is not the key issue. The key issue is that both versions point to the same conclusion: contractor loans are no longer a marginal tool. They are now a meaningful part of the sales machine.

The direct cost is clear. During 2025 the company paid about ILS 4.2 million of interest to mortgage banks for contractor loans, versus ILS 2.4 million in 2024. So even if the model supports sales pace and reduces project-level drawdowns, it is not free. More importantly, it says something about competition: financial incentives have become part of the sector's value proposition, which means sales pace cannot be read as if it were achieved on entirely normal terms.

Competition Did Not Disappear, It Moved Into Credit

Almogim operates in a market where the war and the slowdown pushed many developers toward 20/80 structures and contractor-loan campaigns. The company itself notes that in April 2025 the Bank of Israel issued a temporary order through the end of 2026 aimed at limiting and better monitoring this kind of financing activity. Almogim does not quantify the effect on its business, which is reasonable because the outcome is still uncertain. But the mere fact that the regulator is already engaged shows that financing-supported selling is not a trivial side story.

From a quality-of-earnings perspective, the conclusion is straightforward: Almogim improved operationally, but part of that improvement rests on a more competitive, more financing-dependent, and more expensive selling environment. That is still better than a collapse in demand, but it is not the same thing as clean demand holding up without support.

Cash Flow, Debt And Capital Structure

Cash Framing: all-in cash flexibility

This is the center of the story. When cash is framed on an all-in basis, rather than through net profit, it becomes clear that Almogim is still in the financing stage of its growth cycle. Cash flow from operations was negative ILS 439.4 million, versus positive ILS 61.5 million in 2024. Against that, cash flow from financing was positive ILS 434.8 million, versus negative ILS 103.3 million a year earlier. After all that movement, year-end cash and cash equivalents barely changed, at ILS 29.0 million versus ILS 29.9 million.

This is exactly where the cash label matters. The relevant frame here is all-in cash flexibility, meaning how much cash is left after actual cash uses. This is not the moment to build a normalized maintenance-cash-generation thesis, because the company is still deploying real equity into land, project advancement and execution. Under that frame, 2025 does not look like a year in which the business funded itself.

The balance sheet explains why. Buyer receivables jumped to ILS 247.2 million from only ILS 97.0 million. Construction inventory and land rose to ILS 1.191 billion from ILS 966.4 million. Investments in project companies rose to ILS 181.6 million from ILS 119.8 million. At the same time, buyer advances actually fell to ILS 39.2 million from ILS 62.2 million. In other words, more cash moved deeper into the balance sheet, but not enough moved through to the corporate cash box.

Project Debt Versus Parent Debt

Project debt expanded along with activity. Short-term and long-term bank and other credit at project level reached ILS 816.3 million, versus ILS 562.0 million a year earlier. At the same time, current bond maturities stood at ILS 169.5 million and long-term bonds at ILS 285.0 million. The investor presentation shows total bond debt of about ILS 455 million, which helps explain why public-market access remains so important at the parent layer.

The standalone parent picture is even sharper. Cash at the parent company was only ILS 7.8 million, while contractual principal and interest payments on financial debt totaled about ILS 526.1 million, of which about ILS 196.8 million falls within a year. The company states that it complies with the bond-series XII financial covenants, including minimum equity of ILS 145 million and minimum equity-to-balance-sheet ratio of 14%, and standalone equity stands at ILS 381.6 million. But covenant compliance is not the end of the discussion. It only says there is no formal breach right now. It does not answer where the actual cash path comes from.

There is another detail worth keeping in mind. The trust deed also includes a cross-default clause under which accelerated debt above ILS 20 million, if not cured within 30 days, can trigger an event here as well. That does not look close today, but it is a reminder that the financing layers are connected.

Value Created Is Not Automatically Cash Available

The Roby Capital partnerships in the Amishav and Bialik projects are a good illustration of the gap between value creation and value accessibility. On one hand, the partner funds 80% of required owner equity up to ILS 46.5 million, which materially eases Almogim's equity burden. On the other hand, the distribution waterfall first returns shareholder loans plus 8%, then management-fee adjustments, then allocates until the partner reaches a 17% IRR hurdle, and only after that splits residual upside with 80% to Almogim and 20% to the partner.

The implication is clear: project value created is not automatically equal to cash available to Almogim shareholders. That is exactly why the ILS 26.1 million of other income recognized in 2025, mainly from fair-value recognition, has to be read together with the economic distribution terms, not in isolation. The same goes for the roughly ILS 14 million and ILS 9 million recognized in 2025 in Amishav and Bialik respectively. Accounting is moving faster than cash.

Forecasts And The Road Ahead

Before getting into the details, here are four points that are easy to miss:

• 2026 through 2027 currently look less like harvest years and more like funded proof years. Almogim needs current execution projects to release equity fast enough to support the next growth layer.
• The good news after the balance sheet date, full permitting at Shamayim VeAretz, land financing at Be'er Yaakov, Neve Tzedek sales, and the Yavne East investor term sheet, improves story quality more than it solves the capital problem.
• Urban renewal is already large enough to reshape the company's profile, but much of that value still sits between signatures, permits, project financing and waterfall distributions.
• If the company needs public markets again in 2026, that will not necessarily mean weak operations. It will mean the growth model still has not crossed the point where current execution fully funds the next layer of expansion.

What Actually Has To Happen

The first test is the execution layer. In projects currently under construction, the company still has ILS 360 million of remaining gross profit to recognize and expected surplus release of ILS 721 million. Those are large numbers, but they are not cash in the bank. They still have to travel through construction pace, deliveries, collections, and release of surplus from project-lending accounts. That is why Neve Tzedek, Shamayim VeAretz, ALUMA, Venice and BRAVO matter so much.

In that test, Neve Tzedek is not just a luxury project. It is a translation test. If the 9 apartments sold by year-end 2025 for total consideration of ILS 313 million including VAT turn into orderly collections and deliveries, the market will get evidence that associate-level earnings are not staying on paper. If the pace stalls, that same earnings line will look like it arrived early.

The second test is the land and new-project layer. Here the company has to show capital discipline almost as much as development skill. East Park Yavne, Be'er Yaakov, Chatzavim and South Approaches Haifa can materially expand the revenue base, but they also absorb equity right now. What would improve the read is continued project-level partner funding, not necessarily more parent-level equity.

The third test is the urban-renewal layer. The presentation shows a very large pipeline here, with more than ILS 7 billion of expected revenue in projects where the required majority has already been secured. That is impressive, but the market will not give it full credit without clearer conversion markers: more permits, more projects moving into execution, and more proof that Almogim can finance the path until inventory becomes saleable product.

Why 2026 Through 2027 Look Like A Funded Proof Phase

Management itself reviewed the parent company's liquidity sources through the end of 2027, and the framework it used says a lot. Funding sources include release of equity and profits from projects, unused bank lines, refinancing and bond expansion. This is not the framework of a company that has finished building its balance sheet. It is the framework of a company that believes it can convert larger project scale into greater flexibility over the next two years, but still needs to bridge the way there.

That is why the right forecast label is not simply "another growth year." It is more precise to call 2026 through 2027 a funded proof phase. If Neve Tzedek, Shamayim VeAretz and other key projects keep moving, if investor term sheets become final agreements, and if collections begin to catch up with buyer receivables, then 2025 will look like a successful transition year. If not, Almogim will be left with more assets, more theoretical value and more dependence on outside capital.

Risks

The Main Risk Is Timing, Not Lack Of Opportunity

Almogim has plenty to do. That is exactly what makes capital management sensitive. The number of projects, land positions and urban-renewal initiatives is large enough to create substantial value, but also large enough to create wide timing gaps between equity outflow and equity release. The company itself notes that if timing gaps emerge it can slow entry into new projects or postpone equity injections. That is an important safety valve, but it is also an admission that the pace is not naturally self-protecting.

Accounting Profit Can Arrive Before Cash

Fair-value gains, profit from associates, and recognition in urban-renewal projects are not inherently problematic. They can reflect real value creation. The issue begins when readers translate them straight into a view on financial flexibility. In projects with capital partners, distribution waterfalls and future execution burdens, the path from attractive earnings to cash for common shareholders is still long.

Demand Quality Still Depends On Customer Financing

Contractor loans and 20/80 structures help sales, but they also describe a market that still needs financial support. Any regulatory tightening, change in bank appetite, or additional weakening in demand can affect not only sales pace but also collection quality and financing cost. Anyone looking only at the sales rate is missing the quality of the commercial terms that supported it.

Urban Renewal Is Large, But Slow

The Eisenberg Sitkov West win in Rehovot is a good example. It is a meaningful project, roughly 165 new units replacing 59 existing units, but the company estimates building permits only in about four years. That is real option value, not near-term cash flow. The same timing reality applies to parts of the broader urban-renewal stack.

Actionability For Investors Is Still Limited

The final constraint is liquidity. Even if the business thesis improves, the stock itself still trades on very thin turnover, so any rerating can be slow and uneven. At the same time, the low short position suggests the market is not pricing imminent collapse either. This remains a story of capital execution and cash conversion, not of extreme technical positioning.

---

Conclusions

Almogim exited 2025 as a larger and more ambitious company, with a much broader project base and a clearly improved revenue and earnings line. That is the positive side. The other side is that this pace is still financed externally: public markets, project-level partners and fresh capital carried much of the path.

Over the next few quarters, the market is likely to focus less on whether Almogim has pipeline and more on whether that pipeline starts releasing equity. Collections and deliveries at Neve Tzedek, real progress at Shamayim VeAretz, project-level financing closure in Yavne East, and whether the purchase-tax refund gets closer to actual cash are the checkpoints that can change how the stock is read in the near and medium term.

Current thesis: Almogim already has enough growth engines. The test is whether it can convert them into shareholder-accessible cash without repeatedly needing another financing layer.

What changed versus the simpler legacy view of the company is that the problem is no longer finding the next project. It is carrying all of them together on the balance sheet without exhausting flexibility. The strongest counter-thesis is that 2025 was mostly a year of accounting profit and outside funding, so if housing demand remains dependent on financing incentives and fair-value recognition cools, debt and working-capital weight will matter more than the growth headline. This matters because in residential development, the real edge is not only finding land or projects. It is surviving the bridge period until equity is released.

What would strengthen the thesis over the next 2 to 4 quarters: surplus release from execution projects, collections catching up with receivable growth, project-level partner funding without too much upside surrender, and more urban-renewal projects moving into permitting and execution. What would weaken it: another parent-level capital raise without cash improvement, slower sales without financing support, or a prolonged gap between accounting profit and real cash flow.